Previous 10 | Next 10 |
home / stock / seovf / seovf news
(via TheNewswire) Sernova expands its intellectual property portfolio and capabilities to develop first-in-class cell therapy solutions for type 1 diabetes and other chronic diseases that eliminate the need for life-long immunosuppression drugs LONDON, ONTARIO - Augus...
(via TheNewswire) Veteran Pharmaceutical Executive in Regenerative Medicine Therapeutics to Contribute Corporate Development/ Strategic Expertise to Sernova LONDON, ONTARIO - TheNewswire - July 16, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - June 18, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH ), a clinical-stage regenerative medicine therapeutics company, highlights positive results from its submitted abstract entitled "Clinical Validation of the ...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - June 15, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine therapeutics company, is pleased to announce it has completed the acquisition of cellular local immune protection tec...
Sernova ( OTCQB:SEOVF +7.6% ) to acquire conformal coating cell encapsulation technology from Converge Biotech, accelerating expansion of its regenerative medicine therapeutics platform More news on: Sernova Corp., Healthcare stocks news, Merger & acquisition news, Re...
(via TheNewswire) L ondon, Ontario - TheNewswire - June 8, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF)(FSE:PSH), a clinical-stage regenerative medicine therapeutics company, announced today its acquisition of an innovative cellular immune protection technology. This ...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - June 3, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH ), a clinical-stage regenerative medicine therapeutics company, is pleased to announce that its submitted abstract entitled "Clinical Validation of the Implan...
(via TheNewswire) Sernova to utilize AgeX's UniverCyte TM gene technology to generate transplantable, universal immune-protected therapeutic cells for Sernova's Cell Pouch(TM) Platform ALAMEDA, California & LONDON, Ontario - TheNewswire - May 29, 20...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - May 26, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) (the "Corporation" or "Sernova") announces that the Board of Directors of the Corporation have considered current COVID-19 public health restrictions and dete...
(via TheNewswire) Sernova's Cell Pouch transplanted with Factor VIII corrected human cells shows robust functional blood clotting improvement demonstrating a novel first-in-class ex vivo gene therapy cell-based approach for the treatment of hemophilia A LONDON, ONTARI...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - July 15, 2024 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment o...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...